Merck Expands Protein A Capabilities with JSR Chromatography Acquisition
April 16, 2026
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
False
Advertisement
Bioprocessing
AI and the Future of Bioprocess Labs
March 24, 2026
Modular automation with human oversight across laboratory and manufacturing scales
2 min read
Machine Learning Enables Real-Time Bioprocess Optimization
March 23, 2026
An integrated machine learning framework adapts culture conditions during long perfusion runs
2 min read
Repurposed Drugs Reshape Pricing Debate
March 19, 2026
Study models sustainable pricing for repurposed bevacizumab
2 min read
Mining the Literature for Bioprocess Gains
March 10, 2026
Automated text extraction connects culture conditions, purification steps, and productivity metrics
2 min read
A Simpler, Smarter CHO Strategy for High-Quality Bispecifics
By Yiting Lim
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
Manufacturability and the Winners in Advanced Therapies
By Stephanie Vine
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
The Future of Precision Medicine is Radiopharmaceuticals
By Mona-Elisabeth Rootwelt-Revheim
January 12, 2026
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
5 min read
Building the Future of RNA Manufacturing
By Stefan Lutz
January 6, 2026
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
5 min read
